The Characteristics of Patients Initiated on the First PegIFNα-2a Shot at Week 0
| . | Total (n = 94) . | Group A (n = 51) . | Group B (n = 43) . | P (Group A vs Group B) . |
|---|---|---|---|---|
| Male, No. (%) | 68 (72.3) | 34 (66.7) | 34 (79.0) | NS |
| Age, y | 37.9 ± 8.1 | 37.8 ± 8.6 | 38.0 ± 7.8 | .8887 |
| BMI, kg/m2 | 23.3 ± 2.7 | 22.9 ± 2.9 | 23.7 ± 2.2 | .1284 |
| HBsAg, log10 IU/mL | 4.0 ± 0.6 | 4.0 ± 0.6 | 4.0 ± 0.7 | .9573 |
| HBeAg, log10 PEIU/mL | 2.5 ± 0.9 | 2.3 ± 1.0 | 2.6 ± 0.8 | .0815 |
| HBV DNA, log 10 IU/mL | 7.3 ± 1.4 | 7.3 ± 1.6 | 7.1 ± 1.0 | .3628 |
| ALT, IU/mL | 222.0 ± 182.4 | 248.3 ± 193.1 | 191.0 ± 165.6 | .1326 |
| . | Total (n = 94) . | Group A (n = 51) . | Group B (n = 43) . | P (Group A vs Group B) . |
|---|---|---|---|---|
| Male, No. (%) | 68 (72.3) | 34 (66.7) | 34 (79.0) | NS |
| Age, y | 37.9 ± 8.1 | 37.8 ± 8.6 | 38.0 ± 7.8 | .8887 |
| BMI, kg/m2 | 23.3 ± 2.7 | 22.9 ± 2.9 | 23.7 ± 2.2 | .1284 |
| HBsAg, log10 IU/mL | 4.0 ± 0.6 | 4.0 ± 0.6 | 4.0 ± 0.7 | .9573 |
| HBeAg, log10 PEIU/mL | 2.5 ± 0.9 | 2.3 ± 1.0 | 2.6 ± 0.8 | .0815 |
| HBV DNA, log 10 IU/mL | 7.3 ± 1.4 | 7.3 ± 1.6 | 7.1 ± 1.0 | .3628 |
| ALT, IU/mL | 222.0 ± 182.4 | 248.3 ± 193.1 | 191.0 ± 165.6 | .1326 |
Data are presented as mean ± SD, unless otherwise indicated.
Abbreviations: ALT, alanine aminotransferase; BMI, body mass index; HBV, hepatitis B virus.
The Characteristics of Patients Initiated on the First PegIFNα-2a Shot at Week 0
| . | Total (n = 94) . | Group A (n = 51) . | Group B (n = 43) . | P (Group A vs Group B) . |
|---|---|---|---|---|
| Male, No. (%) | 68 (72.3) | 34 (66.7) | 34 (79.0) | NS |
| Age, y | 37.9 ± 8.1 | 37.8 ± 8.6 | 38.0 ± 7.8 | .8887 |
| BMI, kg/m2 | 23.3 ± 2.7 | 22.9 ± 2.9 | 23.7 ± 2.2 | .1284 |
| HBsAg, log10 IU/mL | 4.0 ± 0.6 | 4.0 ± 0.6 | 4.0 ± 0.7 | .9573 |
| HBeAg, log10 PEIU/mL | 2.5 ± 0.9 | 2.3 ± 1.0 | 2.6 ± 0.8 | .0815 |
| HBV DNA, log 10 IU/mL | 7.3 ± 1.4 | 7.3 ± 1.6 | 7.1 ± 1.0 | .3628 |
| ALT, IU/mL | 222.0 ± 182.4 | 248.3 ± 193.1 | 191.0 ± 165.6 | .1326 |
| . | Total (n = 94) . | Group A (n = 51) . | Group B (n = 43) . | P (Group A vs Group B) . |
|---|---|---|---|---|
| Male, No. (%) | 68 (72.3) | 34 (66.7) | 34 (79.0) | NS |
| Age, y | 37.9 ± 8.1 | 37.8 ± 8.6 | 38.0 ± 7.8 | .8887 |
| BMI, kg/m2 | 23.3 ± 2.7 | 22.9 ± 2.9 | 23.7 ± 2.2 | .1284 |
| HBsAg, log10 IU/mL | 4.0 ± 0.6 | 4.0 ± 0.6 | 4.0 ± 0.7 | .9573 |
| HBeAg, log10 PEIU/mL | 2.5 ± 0.9 | 2.3 ± 1.0 | 2.6 ± 0.8 | .0815 |
| HBV DNA, log 10 IU/mL | 7.3 ± 1.4 | 7.3 ± 1.6 | 7.1 ± 1.0 | .3628 |
| ALT, IU/mL | 222.0 ± 182.4 | 248.3 ± 193.1 | 191.0 ± 165.6 | .1326 |
Data are presented as mean ± SD, unless otherwise indicated.
Abbreviations: ALT, alanine aminotransferase; BMI, body mass index; HBV, hepatitis B virus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
